Education
About Us
Working with TipRanks
Follow Us
Cabaletta Bio (CABA)
NASDAQ:CABA
Total Valuation
Cabaletta Bio has a market cap or net worth of $65.46M. The enterprise value is ―.
Market Cap$65.46M
Enterprise Value―
Share Statistics
Cabaletta Bio has 50,743,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,743,100
Owned by Insiders5.82%
Owned by Institutions0.03%
Financial Efficiency
Cabaletta Bio’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -30.95%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-30.95%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee0.00
Profits Per Employee-420.34K
Employee Count161
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cabaletta Bio is -13.73. Cabaletta Bio’s PEG ratio is 0.05.
PE Ratio-13.73
PS Ratio0.00
PB Ratio0.39
Price to Fair Value3.94
Price to FCF-0.81
Price to Operating Cash Flow-0.83
PEG Ratio0.05
Income Statement
In the last 12 months, Cabaletta Bio had revenue of 0.00 and earned -67.67M in profits. Earnings per share was -1.65.
Revenue0.00
Gross Profit-1.43M
Operating Income-74.66M
Pretax Income-67.67M
Net Income-67.67M
EBITDA-73.23M
Earnings Per Share (EPS)-1.65
Cash Flow
In the last 12 months, operating cash flow was -81.55M and capital expenditures -2.02M, giving a free cash flow of -83.57M billion.
Operating Cash Flow-81.55M
Free Cash Flow-83.57M
Free Cash Flow per Share-1.65
Dividends & Yields
Cabaletta Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.36
52-Week Price Change-89.60%
50-Day Moving Average1.41
200-Day Moving Average3.09
Relative Strength Index (RSI)50.34
Average Volume (3m)819.37K
Important Dates
Cabaletta Bio upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Cabaletta Bio as a current ratio of 15.29, with Debt / Equity ratio of 8.74%
Current Ratio15.29
Quick Ratio15.29
Debt to Market Cap0.00
Net Debt to EBITDA2.57
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cabaletta Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cabaletta Bio EV to EBITDA ratio is -10.12, with an EV/FCF ratio of -13.67.
EV to Sales0.00
EV to EBITDA-10.12
EV to Free Cash Flow-13.67
EV to Operating Cash Flow-13.84
Balance Sheet
Cabaletta Bio has $183.01M in cash and marketable securities with $15.22M in debt, giving a net cash position of -$167.79M billion.
Cash & Marketable Securities$183.01M
Total Debt$15.22M
Net Cash-$167.79M
Net Cash Per Share-$3.31
Tangible Book Value Per Share$5.77
Margins
Gross margin is 71.20%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin71.20%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cabaletta Bio is $15.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.50
Price Target Upside1074.24% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast-40.59%